|
|
UBD601 | 膀胱癌(stage+III-IV)组织组合芯片,附病理分级、TNM和临床分期,60例/60点 | 点 数 | 60 | 例 数 | 60 | 行 数 | 6 | 列 数 | 10 | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | QA/QC | H&E and IHC confirmed | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
|
Legend:
|
|
Malignant (III) Malignant (IV)
|
|
|
|
Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
A1 | 1 | 70 | M | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A2 | 2 | 72 | M | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A3 | 3 | 50 | F | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A4 | 4 | 62 | M | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A5 | 5 | 53 | M | Bladder | Urothelial carcinoma | 1 | T3bN0M0 | III | Malignant | N |
A6 | 6 | 80 | M | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A7 | 7 | 71 | M | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A8 | 8 | 72 | M | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A9 | 9 | 54 | F | Bladder | Urothelial carcinoma | 1 | T3N0M0 | III | Malignant | N |
A10 | 10 | 49 | M | Bladder | Urothelial carcinoma | 2 | T3aN0M0 | III | Malignant | N |
B1 | 11 | 72 | F | Bladder | Urothelial carcinoma | 2 | T3aN0M0 | III | Malignant | N |
B2 | 12 | 60 | M | Bladder | Urothelial carcinoma | 3 | T3aN0M0 | III | Malignant | N |
B3 | 13 | 58 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
B4 | 14 | 67 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
B5 | 15 | 61 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
B6 | 16 | 60 | F | Bladder | Urothelial carcinoma | 3 | T3bN0M0 | III | Malignant | N |
B7 | 17 | 66 | M | Bladder | Urothelial carcinoma | 3 | T4aN0M | III | Malignant | N |
B8 | 18 | 59 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
B9 | 19 | 67 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
B10 | 20 | 75 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
C1 | 21 | 65 | M | Bladder | Urothelial carcinoma with squamous metaplasia | 3 | T3N0M0 | III | Malignant | N |
C2 | 22 | 71 | M | Bladder | Urothelial carcinoma | 3 | T3bN0M0 | III | Malignant | N |
C3 | 23 | 67 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
C4 | 24 | 68 | M | Bladder | Urothelial carcinoma | 2 | T3N0M0 | III | Malignant | N |
C5 | 25 | 70 | M | Bladder | Urothelial carcinoma | 2 | T3N0M0 | III | Malignant | N |
C6 | 26 | 57 | M | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant | N |
C7 | 27 | 67 | M | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant | N |
C8 | 28 | 62 | M | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant | N |
C9 | 29 | 56 | M | Bladder | Urothelial carcinoma with adenoid differentiation | 3 | T3N0M0 | III | Malignant | N |
C10 | 30 | 38 | M | Bladder | Urothelial carcinoma | 3 | T3bN0M0 | III | Malignant | N |
D1 | 31 | 86 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
D2 | 32 | 68 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
D3 | 33 | 70 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
D4 | 34 | 65 | F | Bladder | Urothelial carcinoma | * | T3aN0M0 | III | Malignant | N |
D5 | 35 | 72 | M | Bladder | Urothelial carcinoma | 3 | T3aN0M0 | III | Malignant | N |
D6 | 36 | 50 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
D7 | 37 | 54 | M | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant | N |
D8 | 38 | 52 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
D9 | 39 | 64 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
D10 | 40 | 60 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E1 | 41 | 66 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E2 | 42 | 54 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E3 | 43 | 58 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E4 | 44 | 64 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E5 | 45 | 62 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E6 | 46 | 60 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E7 | 47 | 52 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E8 | 48 | 65 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E9 | 49 | 60 | F | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
E10 | 50 | 74 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
F1 | 51 | 52 | M | Bladder | Urothelial carcinoma with squamous metaplasia | 3 | T3N0M0 | III | Malignant | N |
F2 | 52 | 70 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
F3 | 53 | 65 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
F4 | 54 | 61 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
F5 | 55 | 60 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
F6 | 56 | 42 | M | Bladder | Urothelial carcinoma | 3 | T3N0M0 | III | Malignant | N |
F7 | 57 | 62 | M | Bladder | Urothelial carcinoma | 2 | T3N1M0 | IV | Malignant | N |
F8 | 58 | 33 | M | Bladder | Urothelial carcinoma | 1 | T3N1M0 | IV | Malignant | N |
F9 | 59 | 53 | M | Bladder | Urothelial carcinoma with squamous metaplasia | 3 | T3N1M0 | IV | Malignant | N |
F10 | 60 | 79 | M | Bladder | Urothelial carcinoma | * | T3N1M0 | IV | Malignant | N |
G1 | 61 | | | | | | | | | N |
|
|